Related Experiment Video
Updated: Jul 9, 2026

07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Applied Anatomy of Perimembranous Ventricular Septal Defect for Transcatheter Device Closure
Thao V N Nguyen1, Siew Yen Ho2, Tin N Do3
1Cardiology Department, Children's Hospital 1, Ho Chi Minh City, Vietnam.
JACC. Asia
|July 7, 2026
Summary
Transcatheter device closure effectively treats perimembranous ventricular septal defects (VSDs). This review classifies 7 VSD morphologic variants, guiding device selection and improving procedural outcomes for this common congenital heart disease.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Interventional Cardiology
Background:
- Perimembranous ventricular septal defects (VSDs) are common congenital heart abnormalities.
- Transcatheter device closure is a primary treatment, offering high success and low complication rates.
Purpose of the Study:
- To categorize perimembranous VSDs into distinct morphologic variants.
- To correlate these variants with echocardiographic findings.
- To guide optimal device selection and procedural strategies.
Main Methods:
- Review and categorization of perimembranous VSDs into 7 morphologic types based on anatomical extension.
- Correlation of morphologic types with echocardiographic classifications.
- Analysis of specific VSD types and their associated complications and treatment considerations.
Main Results:
- Seven morphologic variants of perimembranous VSDs are defined (Types 1-7).
- Specific types are associated with unique challenges: Type 2 with aortic valve issues, Type 5 with conduction system proximity, and Types 6/7 with complex extensions.
- Understanding variants aids in selecting appropriate devices and minimizing complications like valve injury or heart block.
Conclusions:
- A detailed morphologic classification of perimembranous VSDs enhances understanding of their anatomical variations.
- Tailoring device selection based on these variants is crucial for successful transcatheter closure.
- This approach optimizes outcomes and reduces complications in treating congenital heart defects.

